Pulmonary Complication following Drug-Eluting Bead Hepatic Chemoembolization.
作者信息
Brown Matthew, Schramm Kristofer, Ryu Robert, Johnson D Thor
机构信息
Department of Radiology, University of Colorado College of Medicine, Aurora, Colorado.
出版信息
Semin Intervent Radiol. 2018 Oct;35(4):359-362. doi: 10.1055/s-0038-1673419. Epub 2018 Nov 5.
Abstract
摘要
相似文献
1
Pulmonary Complication following Drug-Eluting Bead Hepatic Chemoembolization.药物洗脱微球肝动脉化疗栓塞术后的肺部并发症
Semin Intervent Radiol. 2018 Oct;35(4):359-362. doi: 10.1055/s-0038-1673419. Epub 2018 Nov 5.
2
CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.与传统经动脉化疗栓塞术相比，载药微球经导管动脉化疗栓塞术治疗肝细胞癌患者疗效更佳且安全性相当。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819830751. doi: 10.1177/1533033819830751.
3
A lethal complication after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.经动脉化疗栓塞联合载药微球治疗肝细胞癌后的致命并发症。
Case Rep Surg. 2015;2015:873601. doi: 10.1155/2015/873601. Epub 2015 Feb 23.
4
Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.经动脉化疗栓塞治疗肝细胞癌后肝动脉损伤：一项回顾性对照研究中药物洗脱微球与传统化疗栓塞的比较
Acta Radiol. 2017 Feb;58(2):131-139. doi: 10.1177/0284185116648501. Epub 2016 Jul 12.
5
Abdominal Pain Following Drug-eluting Bead Transarterial Chemoembolization.药物洗脱微球经动脉化疗栓塞术后的腹痛
J Clin Exp Hepatol. 2015 Mar;5(1):93-4. doi: 10.1016/j.jceh.2015.01.001. Epub 2015 Jan 10.
6
Comprehensive Analysis of Factors Affecting Clinical Response and Short-Term Survival to Drug-Eluting Bead Transarterial Chemoembolization for Treatment in Patients With Liver Cancer.影响肝癌患者药物洗脱微球经动脉化疗栓塞治疗临床反应及短期生存因素的综合分析
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818759878. doi: 10.1177/1533033818759878.
7
Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma.阿霉素洗脱微球与常规经动脉化疗栓塞治疗肝细胞癌的对比研究。
J Hepatol. 2012 Dec;57(6):1244-50. doi: 10.1016/j.jhep.2012.07.017. Epub 2012 Jul 20.
8
9
Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization.药物洗脱微球经动脉化疗栓塞术后行根治性肝切除治疗巨大肝细胞癌
Intern Med. 2019 Apr 15;58(8):1103-1110. doi: 10.2169/internalmedicine.1214-18. Epub 2019 Jan 10.
10
Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.对超出米兰标准的肝细胞癌患者进行降期治疗：使用载药微球化疗栓塞的策略
J Vasc Interv Radiol. 2013 Nov;24(11):1613-22. doi: 10.1016/j.jvir.2013.07.024. Epub 2013 Sep 20.
本文引用的文献
1
Imaging Predictors of Elevated Lung Shunt Fraction in Patients Being Considered for Yttrium-90 Radioembolization.钇-90放射性栓塞治疗候选患者肺分流分数升高的影像预测因素
J Vasc Interv Radiol. 2015 Oct;26(10):1472-8. doi: 10.1016/j.jvir.2015.07.009. Epub 2015 Aug 18.
2
Transcatheter arterial embolization of hepatic arteriovenous shunts in patients with hepatocellular carcinoma.肝细胞癌患者肝动静脉分流的经导管动脉栓塞术
Semin Intervent Radiol. 2012 Sep;29(3):237-40. doi: 10.1055/s-0032-1326935.
3
Arteriovenous shunts in patients with hepatic tumors.肝肿瘤患者的动静脉分流
J Nucl Med. 1997 Aug;38(8):1201-5.
4
Arteriovenous shunting in hepatocellular carcinoma: its prevalence and clinical significance.肝细胞癌中的动静脉分流：其发生率及临床意义。
Clin Radiol. 1997 Jan;52(1):36-40. doi: 10.1016/s0009-9260(97)80303-0.
Zotero 插件